In this module, we feature an interview with Professor Jay Skyler, who discusses what we are the latest developments in medications preventing or delaying new-onset diabetes, and what are some the challenges clinicians can expect while clinical trials are underway.

Dr. Jay S. Skyler is a Professor of Medicine, Pediatrics, & Psychology at the University of Miami, Miami, Florida, in the Division of Endocrinology, Diabetes, & Metabolism in the Department of Medicine, of which he was the Director from 2000 to 2004; and Deputy Director for Clinical Research and Academic Programs in the Diabetes Research Institute. For 22 years, Dr. Skyler also served as Study Chairman for the National Institute of Diabetes & Digestive & Kidney Diseases Type 1 Diabetes clinical trials network, conducting clinical trials to prevent type 1 diabetes or interdict the type 1 diabetes disease process.

In this module, we invited Dr. Revital Nimri to talk to us about the human factor in the use of diabetes technology. 

Dr Revital Nimri is a senior pediatric endocrinologist and diabetes expert focusing solely on new and innovative technologies for treatment of type 1 diabetes. Her vast experience and contributions in the development of automated insulin delivery systems, the MD-Logic closed-loop system and other decision support systems, regards Dr Nimri as a renowned expert among her international peers. In addition, Dr. Nimri has significant experience and knowledge in designing and performing clinical studies including multi-center & multinational studies.

In this module, we invited Dr. Korey Hood to talk to us about the human factor in the use of diabetes technology. 

Dr. Korey Hood is a clinical psychologist and researcher at Stanford University, where he is Professor of Pediatrics and Psychiatry & Behavioral Sciences. In this interview, Dr. Hood offers his expertise and considerations for future research and clinical care that is aimed at promoting health and quality of life outcomes for PWD.

In this module, we invited ATTD Chairperson, Prof. Battelino to talk to us about Time in Range.

Tadej Battelino is a Professor of Pediatrics at the University of Ljubljana’s Faculty of Medicine and the University Children's Hospital in Slovenia, with over 20 years of experience and expertise in diabetology, pediatrics, and medical technology.

In this module, we invited Professor Satish Garg to talk to us about NAFLD/NASH.

Satish Garg is a Professor of Medicine and Pediatrics at the University of Colorado. Prof. Garg is also Director of the Adult Diabetes program at the Barbara Davis Center for Diabetes, and is the Editor-in-Chief of Diabetes Technology and Therapeutics Journal - the official journal of the ATTD Conference.

In this module, we invited Dr Steven Edelman to talk to us about New Insulin Analogues.

Steven V. Edelman, MD, is Professor of Medicine in the Division of Endocrinology and Metabolism at the University of California, San Diego.  He is also the Director of the Diabetes Care Clinic at the Veteran's Affairs Medical Center in San Diego.  Dr. Edelman is Founder and Executive Director of Taking Control of Your Diabetes, a series of educational and motivational conferences and health fairs for people living with diabetes. 

In this module, we invited Professor Paul Wadwa to talk to us about the Artificial Pancreas system.

Paul Wadwa is the medical director of the pediatric clinic and director of the telemedicine program at the Barbara Davis Center. Prof.Wadwa specialises in Pediatrics - Pediatric Endocrinology at Children's Hospital Colorado, University of Colorado Hospital.

In this module, we invited Professor Bruce Bode to talk to us about Blood Glucose Monitoring and Glycemic Controls used in the Hospital.